139 related articles for article (PubMed ID: 38313450)
41. Dual-tracer PET/CT protocol with [
Wegen S; Weindler J; Voltin CA; van Heek L; Schomäcker K; Fischer T; Marnitz S; Kobe C; Drzezga A; Roth KS
Strahlenther Onkol; 2024 Jan; 200(1):28-38. PubMed ID: 37584717
[TBL] [Abstract][Full Text] [Related]
42. Fibroblast Activation Protein-Targeted PET/CT with
Luo Y; Pan Q; Yang H; Peng L; Zhang W; Li F
J Nucl Med; 2021 Feb; 62(2):266-271. PubMed ID: 32513902
[TBL] [Abstract][Full Text] [Related]
43. A head-to-head comparison of
Qin C; Liu F; Huang J; Ruan W; Liu Q; Gai Y; Hu F; Jiang D; Hu Y; Yang K; Lan X
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3228-3237. PubMed ID: 33609152
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of fibroblast activation protein expressing tumor volume calculated from [
Zhao L; Pang Y; Chen S; Chen J; Li Y; Yu Y; Huang C; Sun L; Wu H; Chen H; Lin Q
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):593-601. PubMed ID: 36222855
[TBL] [Abstract][Full Text] [Related]
45. Molecular imaging of fibroblast activity in pressure overload heart failure using [
Wang G; Yang Q; Wu S; Xu X; Li X; Liang S; Pan G; Zuo C; Zhao X; Cheng C; Liu S
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):465-474. PubMed ID: 36171409
[TBL] [Abstract][Full Text] [Related]
46. Non-tumoral uptake of
Qi N; Wang H; Wang H; Ren S; You Z; Chen X; Guan Y; Xie F; Hua F; Zhao J
Front Oncol; 2022; 12():989595. PubMed ID: 36531015
[TBL] [Abstract][Full Text] [Related]
47.
Dendl K; Koerber SA; Finck R; Mokoala KMG; Staudinger F; Schillings L; Heger U; Röhrich M; Kratochwil C; Sathekge M; Jäger D; Debus J; Haberkorn U; Giesel FL
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4089-4100. PubMed ID: 34050777
[TBL] [Abstract][Full Text] [Related]
48. A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al
Lyu Z; Han W; Zhao H; Jiao Y; Xu P; Wang Y; Shen Q; Yang S; Zhao C; Tian L; Fu P
Front Cardiovasc Med; 2022; 9():921724. PubMed ID: 36072860
[TBL] [Abstract][Full Text] [Related]
49. Head-to-Head Comparison of [
Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
[TBL] [Abstract][Full Text] [Related]
50. Comparison of [
Jiang D; Chen X; You Z; Wang H; Zhang X; Li X; Ren S; Huang Q; Hua F; Guan Y; Zhao J; Xie F
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):732-742. PubMed ID: 34297193
[TBL] [Abstract][Full Text] [Related]
51. Positron emission tomography and computed tomography with [
Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
[TBL] [Abstract][Full Text] [Related]
52. Preclinical Evaluation and a Pilot Clinical Positron Emission Tomography Imaging Study of [
Du X; Gu B; Wang X; Wang X; Ji M; Zhang J; He S; Xu X; Yang Z; Song S
Mol Pharm; 2024 Feb; 21(2):904-915. PubMed ID: 38179677
[TBL] [Abstract][Full Text] [Related]
53. Clinical prospective study of Gallium 68 (
Jinghua L; Kui X; Deliang G; Bo L; Qian Z; Haitao W; Yaqun J; Dongde W; Xigang X; Ping J; Shengli T; Zhiyong Y; Yueming H; Zhonglin Z; Yong H; Yufeng Y
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2152-2166. PubMed ID: 36809426
[TBL] [Abstract][Full Text] [Related]
54. Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management.
Qin C; Song Y; Gai Y; Ruan W; Liu Q; Liu F; Zheng D; Zhang P; Liu H; Zhang T; Tao K; Lan X
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4228-4240. PubMed ID: 35657428
[TBL] [Abstract][Full Text] [Related]
55. Repetitive Early
Glatting FM; Hoppner J; Liew DP; van Genabith A; Spektor AM; Steinbach L; Hubert A; Kratochwil C; Giesel FL; Dendl K; Rathke H; Kauczor HU; Huber PE; Haberkorn U; Röhrich M
J Nucl Med; 2022 Dec; 63(12):1844-1851. PubMed ID: 35618480
[No Abstract] [Full Text] [Related]
56. A comparative study of [
Xi Y; Sun L; Che X; Huang X; Liu H; Wang Q; Meng H; Miao Y; Qu Q; Hai W; Li B; Feng W
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2885-2898. PubMed ID: 37093313
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the diagnostic efficacy of
Zhang Z; Jia G; Pan G; Cao K; Yang Q; Meng H; Yang J; Zhang L; Wang T; Cheng C; Zuo C
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2877-2888. PubMed ID: 35243518
[TBL] [Abstract][Full Text] [Related]
58. Correlation of
Mona CE; Benz MR; Hikmat F; Grogan TR; Lueckerath K; Razmaria A; Riahi R; Slavik R; Girgis MD; Carlucci G; Kelly KA; French SW; Czernin J; Dawson DW; Calais J
J Nucl Med; 2022 Jul; 63(7):1021-1026. PubMed ID: 34740953
[TBL] [Abstract][Full Text] [Related]
59. Feasibility of acquisitions using total-body PET/CT with a half-dose [
Chen Z; Wang Y; Yang X; Li L; Huo Y; Yu X; Xiao X; Zhang C; Chen Y; Zhao H; Zhou Y; Huang G; Liu J; Chen R
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3961-3969. PubMed ID: 37535107
[TBL] [Abstract][Full Text] [Related]
60.
Zhao L; Chen S; Chen S; Pang Y; Dai Y; Hu S; Lin L; Fu L; Sun L; Wu H; Chen H; Lin Q
Radiother Oncol; 2021 May; 158():55-61. PubMed ID: 33621587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
